Abstract
Platelet monoamine oxidase (MAO) activity was studied in three subpopulations of density-fractionated platelets in 15 unmedicated chronic paranoid schizophrenic patients and contrasted with normal controls. No significant difference in MAO activity was found in any of the three platelet fractions in schizophrenics compared to controls. Enzyme kinetic studies performed on the intermediate-density platelet fraction demonstrated no significant differences in V max or Michaelis' constant (K m) between schizophrenics and controls, but showed that the higher platelet MAO activity reported in females compared to male is due to a significantly greater V max rather than altered K m. It is suggested that conflicting results reported in the literature regarding platelet MAO in schizophrenia are not related to the platelet subpopulations studied but are largely due to the selected patient population.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Amorosi E, Garg SK, Karpatkin S (1971) Heterogeneity of human platelets. IV. Identification of young platelet population with (75Se) selenomethionine. Br J Haematol 21:227–232
Belmaker RH, Ebbesen K, Ebstein R, Rimon R (1976) Plalet monoamine oxidase in schizophrenia and manic-depressive illness. Br J Psychiatry 129:227–232
Belmaker R, Reches A, Ebstein RP (1977) Platelet monoamine oxidase in schizophrenia. Lancet II:821
Berrittini WH, Vogel WH, Clouse R (1977) Platelet monoamine oxidase in chronic schizophrenia. Am J Psachiatry 134:805–806
Brockington I, Crow TJ, Johnstone EC, Owen F (1976) An investigation of platelet monoamine oxidase in shcizophrenia and schizoaffective psychosis. Ciba Found Symp 39:353–362
Dixon WJ, Brown MB (1979) Biomedical Computer Programs. P-Series. Berkeley, University of California Press, pp 540–580. BMDP2V Program, Nov. 1979 revision, developed at Health Sciences Computing facility, UCLA, sponsored by NIH Special Research Resources Grant RR-3
Freidhoff AJ, Miller JC, Karpatkin S (1978) Heterogeneity of human platelets. VII. Platelet monoamine oxidase activity in normals and patients with autoimmune thrombocytopenic purpura and reactive thrombocytosis: Its relationship to platelet protein density. Blood 51:317–323
Friedman E, Shopsin B, Sathananthan G, Gershon S (1974) Blood platelet monoamine oxidase activity on psychiatric patients. Am J Psychiatry 131:1392–1394
Giller EL, Bierer L, Rubinow D, Docherty JP (1980) Platelet MAO V max and K m in chronic schizophrenic subjects. Am J Psychiatry 137:97–98
Groshong R, Baldessarini RJ, Gibson A, Lipinski JF, Axelrod D, Pope A (1978) Activities of types A and B MAO and catechol-O-methyl-transferase in blood cells and skin fibroblasts of normal and chronic schizophrenic subjects. Arch Gen Psychiatry 35:1198–1205
Lineweaver H, Burk D (1934) The determination of enzyme dissociation constants. J Am Chem Soc 56:658–666
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265–275
Mann JJ, Thomas KM (1979) Platelet monoamine oxidase activity in schizophrenia. Br J Psychiatry 134:366–371
Mann JJ, Stanley M, Neophytides A, De Leon MJ, Ferris SH, Gershon S (1981) Central amine metabolism in Alzheimer's disease: In vivo relationship to cognitive deficit. Neurobiol Aging (in press)
Meltzer HY, Stahl SM (1974) Platelet monoamine oxidase activity and substrate preferences in schizophrenic patients. Res Commun Chem Pathol Pharmacol 7:419–431
Murphy DL, Belmaker R, Wyatt RJ (1974) Monoamine oxidase in schizophrenia and other behavioral disorders. J Psychiatr Res 11:221–247
Murphy DL, Donnelly CH, Miller L, Wyatt RJ (1976) Platelet monoamine oxidase in chronic schizophrenia. Some enzyme characteristics relevant to reduced activity. Arch Gen Psychiatry 33:1377–1381
Murphy DL, Belmaker R, Carpenter WT, Wyatt RJ (1977) Monoamine oxidase in chronic schizophrenia: Studies of hormonal and other factors affecting enzyme activity. Br J Psychiatry 130:151–158
Murphy DL, Costa JL, Shafer B, Corash L (1978) Monoamine oxidase activity in different density gradient fractions of human platelets. Psychopharmacology 59:193–197
Orsulak PJ, Schildkraut JJ, Schatzberg AF, Herzog JM (1978) Differences in platelet monoamine oxidase activity in subgroups of schizophrenics and depressive disorders. Biol Psychiatry 13:637–647
Overall JE, Gorham DR (1962) The brief psychiatric rating scale. Psychol Rep 10:799–812
Pennington DG, Streatfield K, Roxburgh AE (1976) Megakaryocytes and the heterogeneity of circulating platelets. Br J Haematol 34:639–653
Potkin SG, Cannon HE, Murphy DL, Wyatt RJ (1978) Are paranoid schizophrenics biologically different from other schizophrenics? N Engl J Med 298:61–66
Schizophr Bull 6:2 (1980) Buchsbaum M (ed) Proceedings of NIMH Conference on schizophrenia and platelet monoamine oxidase. Maryland, USA 1979, pp 199–274
Schildkraut JJ, Herzog JM, Orsulak PJ, Edelman SE, Shein HM, Frazier SH (1976) Reduced platelet monoamine oxidase activity in a subgroup of schizophrenic patients. Am J Psychiatry 133:438–440
Spitzer RL, Endicott J, Robins E (1978) Research diagnostic criteria: Rationale and reliability. Arch Gen Psschiatry 36:773–782
Takahashi S, Yamane H, Tani N (1975) Reduction of blood platelet monoamine oxidase activity in schizophrenic patients on phenothiazines. Folia Psychiatr Nsurol Jpn 29:207–214
Winer BJ (1972) Statistical methods in experimental design. Wiley, New York, pp 516–577
Wyatt RJ, Potkin SG, Murphy DL (1979) Platelet monoamine oxidase activity in schizophrenia: A review of the data. Am J Psachiatry 136:377–385
Zeller EA, Boshes B, Davis JM, Thorner M (1975) Molecular aberration in platelet monoamine oxidase in schizophrenia. Lancet I:1385
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mann, J.J., Kaplan, R.D., Georgotas, A. et al. Monoamine oxidase activity and enzyme kinetics in three subpopulations of density-fractionated platelets in chronic paranoid schizophrenics. Psychopharmacology 74, 344–348 (1981). https://doi.org/10.1007/BF00432744
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00432744